These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37558474)

  • 21. Positron emission tomography with 2-[18F]-fluoro-2-deoxy-D-glucose for initial staging of hodgkin lymphoma: a single center experience in Brazil.
    Cerci JJ; Pracchia LF; Soares Junior J; Linardi Cda C; Meneghetti JC; Buccheri V
    Clinics (Sao Paulo); 2009; 64(6):491-8. PubMed ID: 19578651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of positron emission tomography/computed tomography with classical contrast-enhanced computed tomography in the initial staging of Hodgkin lymphoma.
    Bednaruk-Młyński E; Pieńkowska J; Skórzak A; Małkowski B; Kulikowski W; Subocz E; Dzietczenia J; Zalewska M; Leśniewski-Kmak K; Zaucha R; Wróbel T; Zaucha JM
    Leuk Lymphoma; 2015 Feb; 56(2):377-82. PubMed ID: 24794802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current Role of Functional Imaging in the Management of Lymphoma.
    Cheson BD; Meignan M
    Curr Oncol Rep; 2021 Nov; 23(12):144. PubMed ID: 34735647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypermetabolic Unicentric Castleman Disease of Kidney on FDG PET/CT.
    Wang P; Hou G; Li F; Cheng X
    Clin Nucl Med; 2021 Jun; 46(6):510-511. PubMed ID: 33939651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of
    Hyeon CW; Yi HK; Kim EK; Park SJ; Lee SC; Park SW; Oh JK; Choi JY; Chang SA
    Sci Rep; 2020 Dec; 10(1):21524. PubMed ID: 33299053
    [TBL] [Abstract][Full Text] [Related]  

  • 26. (18F)-FDG-PET/MRI of unicentric retroperitoneal Castleman disease in a pediatric patient.
    Rassouli N; Obmann VC; Sandhaus LM; Herrmann KA
    Clin Imaging; 2018; 50():175-180. PubMed ID: 29604602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expert opinions on positron emission tomography and computed tomography imaging in lymphoma.
    Delbeke D; Stroobants S; de Kerviler E; Gisselbrecht C; Meignan M; Conti PS
    Oncologist; 2009; 14 Suppl 2():30-40. PubMed ID: 19819922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Positron emission tomography/computed tomography in the management of Hodgkin and B-cell non-Hodgkin lymphoma: An update.
    Juweid ME; Mueller M; Alhouri A; A-Risheq MZ; Mottaghy FM
    Cancer; 2021 Oct; 127(20):3727-3741. PubMed ID: 34286864
    [No Abstract]   [Full Text] [Related]  

  • 29. Interim FDG-PET has no value in selecting patients who require treatment modification in both early- and advanced-stage Hodgkin lymphoma: response to Adams and Kwee.
    Dann EJ; Paltiel O
    Br J Haematol; 2018 Oct; 183(1):131-133. PubMed ID: 28832981
    [No Abstract]   [Full Text] [Related]  

  • 30. Castleman Disease.
    Wang W; Medeiros LJ
    Surg Pathol Clin; 2019 Sep; 12(3):849-863. PubMed ID: 31352991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. (18)F-fluorodeoxyglucose positron emission tomography/computed tomography comparison of gastric lymphoma and gastric carcinoma.
    Li XF; Fu Q; Dong YW; Liu JJ; Song XY; Dai D; Zuo C; Xu WG
    World J Gastroenterol; 2016 Sep; 22(34):7787-96. PubMed ID: 27678362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic performance of F-18 FDG PET/CT in the detection of bone marrow involvement in paediatric hodgkin lymphoma: A meta-analysis.
    Kim K; Kim SJ
    Leuk Res; 2021 Mar; 102():106525. PubMed ID: 33607533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The full spectrum of Castleman disease: 273 patients studied over 20 years.
    Oksenhendler E; Boutboul D; Fajgenbaum D; Mirouse A; Fieschi C; Malphettes M; Vercellino L; Meignin V; Gérard L; Galicier L
    Br J Haematol; 2018 Jan; 180(2):206-216. PubMed ID: 29143319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone marrow FDG-PET/CT in Hodgkin lymphoma revisited: do imaging and pathology match?
    Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM
    Ann Nucl Med; 2015 Feb; 29(2):132-7. PubMed ID: 25348549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Castleman disease in the hilum liver mimicking the lymph node metastasis of hepatocellular carcinoma on 18F-FDG PET/CT: A case report.
    Hu Y; Liu Y; Shi H
    Medicine (Baltimore); 2018 Mar; 97(12):e9939. PubMed ID: 29561464
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of
    Panebianco M; Bagni O; Cenfra N; Mecarocci S; Ortu La Barbera E; Filippi L; Codacci-Pisanelli G; Biondi T; Laghi A; Cimino G
    Leuk Res; 2019 Jan; 76():48-52. PubMed ID: 30553980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bilateral breast involvement of Hodgkin lymphoma revealed by FDG PET/CT.
    Ergül N; Güner SI; Sağer S; Huq GE; Ciftçi H; Cermik TF
    Med Oncol; 2012 Jun; 29(2):1105-8. PubMed ID: 21373932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hodgkin disease: diagnostic value of FDG PET/CT after first-line therapy--is biopsy of FDG-avid lesions still needed?
    Schaefer NG; Taverna C; Strobel K; Wastl C; Kurrer M; Hany TF
    Radiology; 2007 Jul; 244(1):257-62. PubMed ID: 17581905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Castleman's disease. Large retroperitoneal masses and multiple calcifications detected by
    Xiao L; Zhu HM; Li L
    Hell J Nucl Med; 2019; 22(3):220-221. PubMed ID: 31587031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Positron emission tomography/computed tomography: diagnostic accuracy in lymphoma.
    Hernandez-Maraver D; Hernandez-Navarro F; Gomez-Leon N; Coya J; Rodriguez-Vigil B; Madero R; Pinilla I; Martin-Curto LM
    Br J Haematol; 2006 Nov; 135(3):293-302. PubMed ID: 17032175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.